Ogilvy's John Bell: FDA Social Media Guidelines Will "Basically Follow Same Process" As FTC Blogging Guidelines
John Bell, President of the Board of Word of Mouth Marketing Association and Managing Director, Ogilvy Public Relations Worldwide, was one of the last presenters today at the FDA’s public hearings on “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.” We caught up with Bell late yesterday to get his take on the proceedings.
Asked about how much of the hearings pertained to advertising and how much pertained to PR, Bell said, “Today’s stated focus is about what guidelines should be developed for social media, which is this netherworld in between paid and earned media.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in